

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | plasma membrane repair (GO:0001778) | 6.07582251 |
| 2 | cell-cell junction maintenance (GO:0045217) | 5.70573406 |
| 3 | mannose metabolic process (GO:0006013) | 5.05659252 |
| 4 | hemidesmosome assembly (GO:0031581) | 4.91322231 |
| 5 | actin-myosin filament sliding (GO:0033275) | 4.86975498 |
| 6 | muscle filament sliding (GO:0030049) | 4.86975498 |
| 7 | semaphorin-plexin signaling pathway (GO:0071526) | 4.80407121 |
| 8 | muscle cell fate commitment (GO:0042693) | 4.76968381 |
| 9 | chondrocyte proliferation (GO:0035988) | 4.67057376 |
| 10 | metanephric mesenchyme development (GO:0072075) | 4.62020274 |
| 11 | kidney mesenchyme development (GO:0072074) | 4.42746769 |
| 12 | cell junction maintenance (GO:0034331) | 4.38255717 |
| 13 | actin-mediated cell contraction (GO:0070252) | 4.20255557 |
| 14 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 4.18173818 |
| 15 | activation of MAPKKK activity (GO:0000185) | 4.17158838 |
| 16 | myoblast fusion (GO:0007520) | 4.09823493 |
| 17 | sarcomere organization (GO:0045214) | 4.06355158 |
| 18 | glutathione biosynthetic process (GO:0006750) | 3.99277359 |
| 19 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.87889955 |
| 20 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.86861134 |
| 21 | positive regulation of myotube differentiation (GO:0010831) | 3.80203734 |
| 22 | skeletal muscle fiber development (GO:0048741) | 3.77375881 |
| 23 | cell-substrate junction assembly (GO:0007044) | 3.76501247 |
| 24 | epithelial cell-cell adhesion (GO:0090136) | 3.76051006 |
| 25 | * collagen fibril organization (GO:0030199) | 3.73500642 |
| 26 | regulation of skeletal muscle contraction (GO:0014819) | 3.73165713 |
| 27 | cell adhesion mediated by integrin (GO:0033627) | 3.70080768 |
| 28 | endodermal cell differentiation (GO:0035987) | 3.69936479 |
| 29 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.69440828 |
| 30 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.61531615 |
| 31 | bone trabecula formation (GO:0060346) | 3.60820460 |
| 32 | syncytium formation (GO:0006949) | 3.59560013 |
| 33 | positive regulation of histone deacetylation (GO:0031065) | 3.56228405 |
| 34 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.54921952 |
| 35 | negative regulation of fatty acid transport (GO:2000192) | 3.54349025 |
| 36 | skeletal muscle contraction (GO:0003009) | 3.53357891 |
| 37 | outer ear morphogenesis (GO:0042473) | 3.52737166 |
| 38 | imidazole-containing compound metabolic process (GO:0052803) | 3.51960936 |
| 39 | actin filament-based movement (GO:0030048) | 3.46364234 |
| 40 | negative regulation of macroautophagy (GO:0016242) | 3.39834152 |
| 41 | embryonic cranial skeleton morphogenesis (GO:0048701) | 3.37370435 |
| 42 | negative regulation of cell size (GO:0045792) | 3.36827522 |
| 43 | protein heterotrimerization (GO:0070208) | 3.36715967 |
| 44 | pattern specification involved in kidney development (GO:0061004) | 3.31924928 |
| 45 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 3.30793210 |
| 46 | regulation of ARF GTPase activity (GO:0032312) | 3.27782669 |
| 47 | organ induction (GO:0001759) | 3.27685358 |
| 48 | apoptotic process involved in morphogenesis (GO:0060561) | 3.27564024 |
| 49 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.27492218 |
| 50 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.20764394 |
| 51 | basement membrane organization (GO:0071711) | 3.20636169 |
| 52 | hippo signaling (GO:0035329) | 3.18090800 |
| 53 | protein retention in ER lumen (GO:0006621) | 3.17144462 |
| 54 | regulation of histone deacetylation (GO:0031063) | 3.16449682 |
| 55 | mitochondrion transport along microtubule (GO:0047497) | 3.15038875 |
| 56 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.15038875 |
| 57 | regulation of ruffle assembly (GO:1900027) | 3.13576290 |
| 58 | facial nerve structural organization (GO:0021612) | 3.13357712 |
| 59 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.10720695 |
| 60 | middle ear morphogenesis (GO:0042474) | 3.10225574 |
| 61 | regulation of heart morphogenesis (GO:2000826) | 3.07288459 |
| 62 | endothelial cell morphogenesis (GO:0001886) | 3.06465747 |
| 63 | endocardial cushion development (GO:0003197) | 3.04689873 |
| 64 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.04501190 |
| 65 | cochlea morphogenesis (GO:0090103) | 3.04370459 |
| 66 | iron coordination entity transport (GO:1901678) | 3.04222063 |
| 67 | adherens junction assembly (GO:0034333) | 3.03375955 |
| 68 | embryonic body morphogenesis (GO:0010172) | 3.02793866 |
| 69 | positive regulation of p38MAPK cascade (GO:1900745) | 3.02636466 |
| 70 | cardiac myofibril assembly (GO:0055003) | 3.01811415 |
| 71 | renal filtration (GO:0097205) | 3.00682484 |
| 72 | body morphogenesis (GO:0010171) | 2.99151717 |
| 73 | regulation of early endosome to late endosome transport (GO:2000641) | 2.98844223 |
| 74 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.98185532 |
| 75 | actomyosin structure organization (GO:0031032) | 2.97865524 |
| 76 | wound healing, spreading of epidermal cells (GO:0035313) | 2.96170899 |
| 77 | UV protection (GO:0009650) | 2.95774321 |
| 78 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.95141921 |
| 79 | positive regulation of mast cell degranulation (GO:0043306) | 2.95141921 |
| 80 | cellular response to vitamin D (GO:0071305) | 2.94813748 |
| 81 | response to parathyroid hormone (GO:0071107) | 2.94183029 |
| 82 | myotube cell development (GO:0014904) | 2.93830413 |
| 83 | proximal/distal pattern formation (GO:0009954) | 2.92518788 |
| 84 | peptide biosynthetic process (GO:0043043) | 2.92373502 |
| 85 | negative regulation of cartilage development (GO:0061037) | 2.89315849 |
| 86 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.86582732 |
| 87 | positive regulation of action potential (GO:0045760) | 2.86455959 |
| 88 | regulation of cardioblast proliferation (GO:0003264) | 2.84881735 |
| 89 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.84881735 |
| 90 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.84382621 |
| 91 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.84260159 |
| 92 | positive regulation of protein deacetylation (GO:0090312) | 2.84103787 |
| 93 | cell-substrate adherens junction assembly (GO:0007045) | 2.82654654 |
| 94 | focal adhesion assembly (GO:0048041) | 2.82654654 |
| 95 | cellular response to vitamin (GO:0071295) | 2.82227084 |
| 96 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.82101752 |
| 97 | GDP-mannose metabolic process (GO:0019673) | 2.81531739 |
| 98 | regulation of tight junction assembly (GO:2000810) | 2.81386345 |
| 99 | axon extension involved in axon guidance (GO:0048846) | 2.81291242 |
| 100 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.81291242 |
| 101 | positive regulation of skeletal muscle tissue development (GO:0048643) | 2.81161867 |
| 102 | regulation of p38MAPK cascade (GO:1900744) | 2.79711335 |
| 103 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.79410981 |
| 104 | mRNA transcription (GO:0009299) | 2.78855861 |
| 105 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.78396421 |
| 106 | nephron tubule formation (GO:0072079) | 2.76961009 |
| 107 | craniofacial suture morphogenesis (GO:0097094) | 2.76024364 |
| 108 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.76007567 |
| 109 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.75359451 |
| 110 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.74330491 |
| 111 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.74301197 |
| 112 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.74107976 |
| 113 | non-canonical Wnt signaling pathway (GO:0035567) | 2.73980256 |
| 114 | cranial nerve morphogenesis (GO:0021602) | 2.73639743 |
| 115 | ear development (GO:0043583) | 2.73545748 |
| 116 | glomerular basement membrane development (GO:0032836) | 2.73524878 |
| 117 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.73442697 |
| 118 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.70982931 |
| 119 | polarized epithelial cell differentiation (GO:0030859) | 2.69769205 |
| 120 | positive regulation of receptor recycling (GO:0001921) | 2.68737495 |
| 121 | respiratory system process (GO:0003016) | 2.68591070 |
| 122 | muscle cell migration (GO:0014812) | 2.65800818 |
| 123 | myofibril assembly (GO:0030239) | 2.65418935 |
| 124 | collagen metabolic process (GO:0032963) | 2.64745490 |
| 125 | negative regulation of catenin import into nucleus (GO:0035414) | 2.64141691 |
| 126 | wound healing, spreading of cells (GO:0044319) | 2.64000811 |
| 127 | paraxial mesoderm development (GO:0048339) | 2.63991073 |
| 128 | protein insertion into membrane (GO:0051205) | 2.63452173 |
| 129 | neuronal ion channel clustering (GO:0045161) | 2.62960697 |
| 130 | muscle organ development (GO:0007517) | 2.61191600 |
| 131 | peptidyl-proline hydroxylation (GO:0019511) | 2.61095926 |
| 132 | cAMP biosynthetic process (GO:0006171) | 2.60344116 |
| 133 | regulation of hippo signaling (GO:0035330) | 2.60060447 |
| 134 | glial cell migration (GO:0008347) | 2.59728515 |
| 135 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.59390118 |
| 136 | cellular component maintenance (GO:0043954) | 2.59177405 |
| 137 | regulation of protein kinase C signaling (GO:0090036) | 2.58869550 |
| 138 | regulation of establishment of planar polarity (GO:0090175) | 2.58322640 |
| 139 | embryonic camera-type eye development (GO:0031076) | 2.57652800 |
| 140 | muscle structure development (GO:0061061) | 2.57517755 |
| 141 | establishment of mitochondrion localization (GO:0051654) | 2.57401278 |
| 142 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.57324556 |
| 143 | positive regulation of vesicle fusion (GO:0031340) | 2.57159662 |
| 144 | collagen catabolic process (GO:0030574) | 2.57141209 |
| 145 | collecting duct development (GO:0072044) | 2.56603546 |
| 146 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.55573935 |
| 147 | stress fiber assembly (GO:0043149) | 2.55480789 |
| 148 | * mesenchyme development (GO:0060485) | 2.54836686 |
| 149 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.54816914 |
| 150 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.54565225 |
| 151 | skin morphogenesis (GO:0043589) | 2.54328661 |
| 152 | protein targeting to plasma membrane (GO:0072661) | 2.54112252 |
| 153 | response to manganese ion (GO:0010042) | 2.53457521 |
| 154 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.52386960 |
| 155 | virion attachment to host cell (GO:0019062) | 2.50855226 |
| 156 | adhesion of symbiont to host cell (GO:0044650) | 2.50855226 |
| 157 | autophagic vacuole assembly (GO:0000045) | 2.50337057 |
| 158 | peptide catabolic process (GO:0043171) | 2.46799298 |
| 159 | cell proliferation in forebrain (GO:0021846) | 2.46193630 |
| 160 | response to magnesium ion (GO:0032026) | 2.46076349 |
| 161 | glucose 6-phosphate metabolic process (GO:0051156) | 2.42209488 |
| 162 | positive regulation of synapse maturation (GO:0090129) | 2.42155517 |
| 163 | activation of Rac GTPase activity (GO:0032863) | 2.41251101 |
| 164 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.41077405 |
| 165 | adenosine receptor signaling pathway (GO:0001973) | 2.40466090 |
| 166 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.36834427 |
| 167 | apoptotic process involved in development (GO:1902742) | 2.36014732 |
| 168 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.33847032 |
| 169 | positive regulation of protein kinase C signaling (GO:0090037) | 2.33593127 |
| 170 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.33147363 |
| 171 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.32150507 |
| 172 | establishment of monopolar cell polarity (GO:0061162) | 2.32150507 |
| 173 | white fat cell differentiation (GO:0050872) | 2.31657045 |
| 174 | glycosphingolipid catabolic process (GO:0046479) | 2.31413954 |
| 175 | dopamine receptor signaling pathway (GO:0007212) | 2.31142568 |
| 176 | specification of organ identity (GO:0010092) | 2.30785122 |
| 177 | metanephric nephron epithelium development (GO:0072243) | 2.30282902 |
| 178 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.30030521 |
| 179 | positive regulation of filopodium assembly (GO:0051491) | 2.29927201 |
| 180 | synaptic vesicle endocytosis (GO:0048488) | 2.29867363 |
| 181 | adhesion of symbiont to host (GO:0044406) | 2.29014474 |
| 182 | tooth mineralization (GO:0034505) | 2.27834363 |
| 183 | positive regulation of leukocyte degranulation (GO:0043302) | 2.27555584 |
| 184 | positive regulation of T cell apoptotic process (GO:0070234) | 2.25677093 |
| 185 | activation of JUN kinase activity (GO:0007257) | 2.25565488 |
| 186 | renal system development (GO:0072001) | 2.24699091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 6.01661084 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.14079477 |
| 3 | * TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.52533965 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.25378527 |
| 5 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.12699502 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.74146764 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.69727141 |
| 8 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.62835692 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.60292245 |
| 10 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.46822608 |
| 11 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.38294331 |
| 12 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 2.37761360 |
| 13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.26933019 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.21099031 |
| 15 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 2.08225227 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.06347401 |
| 17 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.05893088 |
| 18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.04606104 |
| 19 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.03050567 |
| 20 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.01907158 |
| 21 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.01813061 |
| 22 | P68_20966046_ChIP-Seq_HELA_Human | 2.00802580 |
| 23 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.99737722 |
| 24 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.96677404 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.91254016 |
| 26 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.83430083 |
| 27 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.81559240 |
| 28 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.81263971 |
| 29 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.80144435 |
| 30 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.79055868 |
| 31 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.75220394 |
| 32 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.75220394 |
| 33 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.75021287 |
| 34 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.74741715 |
| 35 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.71119403 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.70567643 |
| 37 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.69348042 |
| 38 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.67605395 |
| 39 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.66710377 |
| 40 | ATF3_27146783_Chip-Seq_COLON_Human | 1.66499043 |
| 41 | KDM2B_26808549_Chip-Seq_K562_Human | 1.66092872 |
| 42 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.65310290 |
| 43 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.65221917 |
| 44 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.64411344 |
| 45 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.64341270 |
| 46 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.62623202 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.61573029 |
| 48 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.60598084 |
| 49 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.60598084 |
| 50 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.60417135 |
| 51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.60337154 |
| 52 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.58966619 |
| 53 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.56985216 |
| 54 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.56985216 |
| 55 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.56934928 |
| 56 | CJUN_26792858_Chip-Seq_BT549_Human | 1.56912502 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.55773991 |
| 58 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.55348775 |
| 59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54104354 |
| 60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54082231 |
| 61 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.54074907 |
| 62 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.53968707 |
| 63 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.52992063 |
| 64 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.50771044 |
| 65 | MYC_22102868_ChIP-Seq_BL_Human | 1.48243257 |
| 66 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.47304173 |
| 67 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.45097500 |
| 68 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.44281755 |
| 69 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.43902474 |
| 70 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.43901286 |
| 71 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.43797904 |
| 72 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43752166 |
| 73 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.42272897 |
| 74 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.41966011 |
| 75 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.40664333 |
| 76 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40308549 |
| 77 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.39179789 |
| 78 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.39040333 |
| 79 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38809062 |
| 80 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.38609835 |
| 81 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.38164914 |
| 82 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.38117604 |
| 83 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.37822044 |
| 84 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.37700227 |
| 85 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.36433536 |
| 86 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35515389 |
| 87 | * SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.34929404 |
| 88 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.33481232 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.30525399 |
| 90 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.28264304 |
| 91 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.28163523 |
| 92 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.27736374 |
| 93 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27719592 |
| 94 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.27535266 |
| 95 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.26472746 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.25692769 |
| 97 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.25350643 |
| 98 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.22200900 |
| 99 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.21502513 |
| 100 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.20608054 |
| 101 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.20590199 |
| 102 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.19903170 |
| 103 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19511429 |
| 104 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19369241 |
| 105 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.19188633 |
| 106 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.19182486 |
| 107 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.18098457 |
| 108 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.17927412 |
| 109 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17799687 |
| 110 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.17540642 |
| 111 | SA1_27219007_Chip-Seq_Bcells_Human | 1.17467802 |
| 112 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.16993738 |
| 113 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.16749201 |
| 114 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.15492854 |
| 115 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.15449804 |
| 116 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.14812813 |
| 117 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.13693568 |
| 118 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13412438 |
| 119 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.13257057 |
| 120 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.13132404 |
| 121 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.11812525 |
| 122 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.11618077 |
| 123 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.11428098 |
| 124 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.11332691 |
| 125 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.11215919 |
| 126 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.10955548 |
| 127 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.10755117 |
| 128 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.10376658 |
| 129 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.10265217 |
| 130 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.09182596 |
| 131 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.09122733 |
| 132 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.08649175 |
| 133 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08278448 |
| 134 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08211543 |
| 135 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07949299 |
| 136 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.07668655 |
| 137 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06964855 |
| 138 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.06760649 |
| 139 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.06025839 |
| 140 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05156338 |
| 141 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.05063381 |
| 142 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04811533 |
| 143 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.04685381 |
| 144 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04218737 |
| 145 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.03980504 |
| 146 | MAF_26560356_Chip-Seq_TH2_Human | 1.03260974 |
| 147 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.03118592 |
| 148 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.02702692 |
| 149 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.02364113 |
| 150 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01990236 |
| 151 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.99778845 |
| 152 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99601181 |
| 153 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98069457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.14778410 |
| 2 | MP0009840_abnormal_foam_cell | 3.90345393 |
| 3 | MP0005623_abnormal_meninges_morphology | 3.59620989 |
| 4 | MP0000751_myopathy | 3.53744076 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.36951494 |
| 6 | MP0010030_abnormal_orbit_morphology | 3.35313262 |
| 7 | MP0003879_abnormal_hair_cell | 3.26948198 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 3.23835841 |
| 9 | MP0000733_abnormal_muscle_development | 2.86940096 |
| 10 | MP0000749_muscle_degeneration | 2.70230855 |
| 11 | MP0004233_abnormal_muscle_weight | 2.54233005 |
| 12 | * MP0005503_abnormal_tendon_morphology | 2.42272968 |
| 13 | MP0005275_abnormal_skin_tensile | 2.41891518 |
| 14 | MP0000750_abnormal_muscle_regeneration | 2.39979075 |
| 15 | MP0003385_abnormal_body_wall | 2.38993281 |
| 16 | MP0005257_abnormal_intraocular_pressure | 2.38060676 |
| 17 | MP0003787_abnormal_imprinting | 2.33490711 |
| 18 | MP0003646_muscle_fatigue | 2.31330408 |
| 19 | MP0004272_abnormal_basement_membrane | 2.15501381 |
| 20 | MP0009250_abnormal_appendicular_skeleto | 2.11982287 |
| 21 | MP0003279_aneurysm | 2.10639586 |
| 22 | MP0005451_abnormal_body_composition | 2.07069649 |
| 23 | MP0003566_abnormal_cell_adhesion | 2.06096054 |
| 24 | MP0003183_abnormal_peptide_metabolism | 2.04846069 |
| 25 | MP0002877_abnormal_melanocyte_morpholog | 2.03510609 |
| 26 | MP0004145_abnormal_muscle_electrophysio | 2.01807804 |
| 27 | MP0000747_muscle_weakness | 2.00053966 |
| 28 | MP0003453_abnormal_keratinocyte_physiol | 1.99285311 |
| 29 | MP0000759_abnormal_skeletal_muscle | 1.97485882 |
| 30 | MP0003941_abnormal_skin_development | 1.94370134 |
| 31 | MP0004087_abnormal_muscle_fiber | 1.92061434 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.85778165 |
| 33 | MP0000013_abnormal_adipose_tissue | 1.84194045 |
| 34 | MP0009053_abnormal_anal_canal | 1.83783391 |
| 35 | MP0004084_abnormal_cardiac_muscle | 1.79051827 |
| 36 | MP0002269_muscular_atrophy | 1.77296066 |
| 37 | MP0004510_myositis | 1.77043607 |
| 38 | MP0001958_emphysema | 1.72974447 |
| 39 | MP0003942_abnormal_urinary_system | 1.71630172 |
| 40 | MP0001299_abnormal_eye_distance/ | 1.69765014 |
| 41 | MP0005666_abnormal_adipose_tissue | 1.69451301 |
| 42 | MP0000534_abnormal_ureter_morphology | 1.69271441 |
| 43 | MP0002060_abnormal_skin_morphology | 1.68867688 |
| 44 | MP0000428_abnormal_craniofacial_morphol | 1.68005772 |
| 45 | MP0001873_stomach_inflammation | 1.66714920 |
| 46 | MP0005083_abnormal_biliary_tract | 1.63824222 |
| 47 | MP0000678_abnormal_parathyroid_gland | 1.62836754 |
| 48 | MP0000681_abnormal_thyroid_gland | 1.62685960 |
| 49 | MP0005330_cardiomyopathy | 1.60572621 |
| 50 | * MP0002108_abnormal_muscle_morphology | 1.58739817 |
| 51 | MP0000762_abnormal_tongue_morphology | 1.58142361 |
| 52 | MP0009384_cardiac_valve_regurgitation | 1.57912365 |
| 53 | MP0002106_abnormal_muscle_physiology | 1.55356645 |
| 54 | MP0002837_dystrophic_cardiac_calcinosis | 1.55315610 |
| 55 | MP0003091_abnormal_cell_migration | 1.53197829 |
| 56 | MP0001346_abnormal_lacrimal_gland | 1.48390857 |
| 57 | MP0002249_abnormal_larynx_morphology | 1.47604698 |
| 58 | * MP0005369_muscle_phenotype | 1.46733362 |
| 59 | * MP0005508_abnormal_skeleton_morphology | 1.46226188 |
| 60 | MP0005670_abnormal_white_adipose | 1.43200163 |
| 61 | MP0005023_abnormal_wound_healing | 1.36554721 |
| 62 | MP0003755_abnormal_palate_morphology | 1.36435090 |
| 63 | MP0000537_abnormal_urethra_morphology | 1.33191083 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 1.29382365 |
| 65 | MP0002254_reproductive_system_inflammat | 1.29282008 |
| 66 | MP0000049_abnormal_middle_ear | 1.27690772 |
| 67 | MP0002735_abnormal_chemical_nociception | 1.27594553 |
| 68 | MP0001849_ear_inflammation | 1.26839772 |
| 69 | MP0002932_abnormal_joint_morphology | 1.26770073 |
| 70 | MP0001348_abnormal_lacrimal_gland | 1.22284376 |
| 71 | MP0003283_abnormal_digestive_organ | 1.20966462 |
| 72 | MP0002234_abnormal_pharynx_morphology | 1.20765258 |
| 73 | MP0005409_darkened_coat_color | 1.19172762 |
| 74 | MP0000003_abnormal_adipose_tissue | 1.19143754 |
| 75 | MP0002896_abnormal_bone_mineralization | 1.18130597 |
| 76 | MP0003123_paternal_imprinting | 1.17929823 |
| 77 | MP0004130_abnormal_muscle_cell | 1.17820303 |
| 78 | MP0003937_abnormal_limbs/digits/tail_de | 1.16159193 |
| 79 | MP0000767_abnormal_smooth_muscle | 1.16009157 |
| 80 | MP0002233_abnormal_nose_morphology | 1.14806892 |
| 81 | MP0010630_abnormal_cardiac_muscle | 1.11011107 |
| 82 | MP0003115_abnormal_respiratory_system | 1.10604053 |
| 83 | MP0001502_abnormal_circadian_rhythm | 1.10059922 |
| 84 | MP0002168_other_aberrant_phenotype | 1.03455850 |
| 85 | MP0009780_abnormal_chondrocyte_physiolo | 1.03361684 |
| 86 | MP0004036_abnormal_muscle_relaxation | 1.03236114 |
| 87 | MP0002114_abnormal_axial_skeleton | 1.01666329 |
| 88 | MP0004859_abnormal_synaptic_plasticity | 1.00919537 |
| 89 | MP0002972_abnormal_cardiac_muscle | 1.00896816 |
| 90 | MP0002184_abnormal_innervation | 1.00621609 |
| 91 | MP0000163_abnormal_cartilage_morphology | 1.00620272 |
| 92 | MP0005620_abnormal_muscle_contractility | 1.00273709 |
| 93 | MP0002332_abnormal_exercise_endurance | 1.00272277 |
| 94 | MP0003935_abnormal_craniofacial_develop | 0.99740721 |
| 95 | MP0005248_abnormal_Harderian_gland | 0.99653771 |
| 96 | MP0002822_catalepsy | 0.96984988 |
| 97 | MP0003122_maternal_imprinting | 0.96733901 |
| 98 | MP0010386_abnormal_urinary_bladder | 0.96231277 |
| 99 | MP0002282_abnormal_trachea_morphology | 0.96112834 |
| 100 | MP0008260_abnormal_autophagy | 0.95186752 |
| 101 | MP0001542_abnormal_bone_strength | 0.95142108 |
| 102 | MP0004381_abnormal_hair_follicle | 0.94327449 |
| 103 | MP0003806_abnormal_nucleotide_metabolis | 0.93761444 |
| 104 | MP0002177_abnormal_outer_ear | 0.93121279 |
| 105 | MP0005381_digestive/alimentary_phenotyp | 0.92969358 |
| 106 | MP0001663_abnormal_digestive_system | 0.92800949 |
| 107 | MP0005197_abnormal_uvea_morphology | 0.92528695 |
| 108 | * MP0002115_abnormal_skeleton_extremities | 0.92257568 |
| 109 | MP0006138_congestive_heart_failure | 0.90953055 |
| 110 | MP0000467_abnormal_esophagus_morphology | 0.90183362 |
| 111 | MP0005076_abnormal_cell_differentiation | 0.89857537 |
| 112 | MP0002971_abnormal_brown_adipose | 0.89771760 |
| 113 | MP0005377_hearing/vestibular/ear_phenot | 0.87701720 |
| 114 | MP0003878_abnormal_ear_physiology | 0.87701720 |
| 115 | MP0001340_abnormal_eyelid_morphology | 0.87416949 |
| 116 | MP0001270_distended_abdomen | 0.87330458 |
| 117 | MP0003300_gastrointestinal_ulcer | 0.85860696 |
| 118 | MP0002116_abnormal_craniofacial_bone | 0.85405133 |
| 119 | MP0002796_impaired_skin_barrier | 0.83210451 |
| 120 | MP0000432_abnormal_head_morphology | 0.82414119 |
| 121 | MP0005423_abnormal_somatic_nervous | 0.80378002 |
| 122 | * MP0002109_abnormal_limb_morphology | 0.80096244 |
| 123 | MP0003329_amyloid_beta_deposits | 0.79756011 |
| 124 | MP0004858_abnormal_nervous_system | 0.77067659 |
| 125 | MP0002734_abnormal_mechanical_nocicepti | 0.76551803 |
| 126 | MP0002089_abnormal_postnatal_growth/wei | 0.76497597 |
| 127 | MP0004185_abnormal_adipocyte_glucose | 0.76053294 |
| 128 | MP0005595_abnormal_vascular_smooth | 0.74657415 |
| 129 | MP0003191_abnormal_cellular_cholesterol | 0.73753653 |
| 130 | * MP0002113_abnormal_skeleton_development | 0.73734212 |
| 131 | MP0004197_abnormal_fetal_growth/weight/ | 0.71902545 |
| 132 | MP0010234_abnormal_vibrissa_follicle | 0.71307505 |
| 133 | MP0005193_abnormal_anterior_eye | 0.71163457 |
| 134 | MP0001544_abnormal_cardiovascular_syste | 0.71027845 |
| 135 | MP0005385_cardiovascular_system_phenoty | 0.71027845 |
| 136 | MP0000026_abnormal_inner_ear | 0.70967438 |
| 137 | MP0003436_decreased_susceptibility_to | 0.70633834 |
| 138 | MP0001970_abnormal_pain_threshold | 0.70587039 |
| 139 | MP0002998_abnormal_bone_remodeling | 0.70058102 |
| 140 | MP0010368_abnormal_lymphatic_system | 0.69923218 |
| 141 | MP0008007_abnormal_cellular_replicative | 0.69893671 |
| 142 | MP0004133_heterotaxia | 0.69529212 |
| 143 | MP0005375_adipose_tissue_phenotype | 0.68695527 |
| 144 | MP0001243_abnormal_dermal_layer | 0.67468427 |
| 145 | MP0002733_abnormal_thermal_nociception | 0.67271773 |
| 146 | MP0002092_abnormal_eye_morphology | 0.66898060 |
| 147 | MP0002128_abnormal_blood_circulation | 0.66779253 |
| 148 | * MP0005390_skeleton_phenotype | 0.65839964 |
| 149 | MP0003634_abnormal_glial_cell | 0.65553828 |
| 150 | MP0002933_joint_inflammation | 0.65440390 |
| 151 | MP0008775_abnormal_heart_ventricle | 0.64874915 |
| 152 | MP0000470_abnormal_stomach_morphology | 0.63672220 |
| 153 | MP0003638_abnormal_response/metabolism_ | 0.63450419 |
| 154 | MP0005501_abnormal_skin_physiology | 0.60558839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 1 muscle fiber predominance (HP:0003803) | 4.87988181 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.82301569 |
| 3 | Stridor (HP:0010307) | 4.53748030 |
| 4 | Popliteal pterygium (HP:0009756) | 4.31496830 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.27648185 |
| 6 | Protrusio acetabuli (HP:0003179) | 4.20236904 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 4.08143187 |
| 8 | Round ear (HP:0100830) | 4.07145367 |
| 9 | Fetal akinesia sequence (HP:0001989) | 3.95716249 |
| 10 | Aplasia of the musculature (HP:0100854) | 3.89844993 |
| 11 | J-shaped sella turcica (HP:0002680) | 3.88753941 |
| 12 | Nemaline bodies (HP:0003798) | 3.81305923 |
| 13 | Increased connective tissue (HP:0009025) | 3.68433079 |
| 14 | Malignant hyperthermia (HP:0002047) | 3.67950363 |
| 15 | Distal arthrogryposis (HP:0005684) | 3.62804955 |
| 16 | Muscle fiber splitting (HP:0003555) | 3.53882709 |
| 17 | Obstructive sleep apnea (HP:0002870) | 3.52989407 |
| 18 | Difficulty climbing stairs (HP:0003551) | 3.52592807 |
| 19 | Shallow orbits (HP:0000586) | 3.42400323 |
| 20 | Amniotic constriction ring (HP:0009775) | 3.39559433 |
| 21 | Abnormality of placental membranes (HP:0011409) | 3.39559433 |
| 22 | Pterygium (HP:0001059) | 3.38683964 |
| 23 | Fatigable weakness (HP:0003473) | 3.31449016 |
| 24 | Abnormality of the neuromuscular junction (HP:0003398) | 3.31449016 |
| 25 | Thin ribs (HP:0000883) | 3.28316175 |
| 26 | Hyporeflexia of lower limbs (HP:0002600) | 3.21828538 |
| 27 | Calcaneovalgus deformity (HP:0001848) | 3.19909846 |
| 28 | Scapular winging (HP:0003691) | 3.13588638 |
| 29 | Joint stiffness (HP:0001387) | 3.13293577 |
| 30 | Deformed tarsal bones (HP:0008119) | 3.10273200 |
| 31 | Increased variability in muscle fiber diameter (HP:0003557) | 3.09132061 |
| 32 | Absent phalangeal crease (HP:0006109) | 3.05567370 |
| 33 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.03125190 |
| 34 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.03063150 |
| 35 | Abnormality of the calf musculature (HP:0001430) | 3.01176668 |
| 36 | Dysostosis multiplex (HP:0000943) | 2.97594222 |
| 37 | Type 2 muscle fiber atrophy (HP:0003554) | 2.92509857 |
| 38 | Diaphragmatic weakness (HP:0009113) | 2.92440204 |
| 39 | Weak cry (HP:0001612) | 2.92351539 |
| 40 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.90916136 |
| 41 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.90916136 |
| 42 | Abnormality of glycolipid metabolism (HP:0010969) | 2.90916136 |
| 43 | Muscle fiber atrophy (HP:0100295) | 2.83798714 |
| 44 | Ankle contracture (HP:0006466) | 2.83305686 |
| 45 | Asymmetric septal hypertrophy (HP:0001670) | 2.82996419 |
| 46 | Nuclear cataract (HP:0100018) | 2.82670010 |
| 47 | Ulnar bowing (HP:0003031) | 2.79343450 |
| 48 | Spinal rigidity (HP:0003306) | 2.78446428 |
| 49 | Difficulty running (HP:0009046) | 2.78183318 |
| 50 | Ulnar deviation of the wrist (HP:0003049) | 2.77085276 |
| 51 | Broad face (HP:0000283) | 2.76939900 |
| 52 | Atrophic scars (HP:0001075) | 2.75242462 |
| 53 | Abnormality of the calcaneus (HP:0008364) | 2.74957324 |
| 54 | Hip contracture (HP:0003273) | 2.72618294 |
| 55 | Fragile skin (HP:0001030) | 2.71852386 |
| 56 | Hyperthyroidism (HP:0000836) | 2.68691800 |
| 57 | Broad metatarsal (HP:0001783) | 2.68365523 |
| 58 | EMG: myopathic abnormalities (HP:0003458) | 2.66055124 |
| 59 | Cerebral aneurysm (HP:0004944) | 2.64808989 |
| 60 | Gowers sign (HP:0003391) | 2.62630476 |
| 61 | Thin bony cortex (HP:0002753) | 2.62080467 |
| 62 | Mucopolysacchariduria (HP:0008155) | 2.53940941 |
| 63 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.53940941 |
| 64 | Akinesia (HP:0002304) | 2.52133095 |
| 65 | Distal lower limb amyotrophy (HP:0008944) | 2.51479202 |
| 66 | Abnormal finger flexion creases (HP:0006143) | 2.50904416 |
| 67 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.48804682 |
| 68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.48804682 |
| 69 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.48804682 |
| 70 | Cervical subluxation (HP:0003308) | 2.48659551 |
| 71 | Deformed sella turcica (HP:0002681) | 2.45285085 |
| 72 | Thoracic kyphosis (HP:0002942) | 2.44126740 |
| 73 | Right ventricular cardiomyopathy (HP:0011663) | 2.43462335 |
| 74 | Limb-girdle muscle atrophy (HP:0003797) | 2.43020589 |
| 75 | Myopathic facies (HP:0002058) | 2.38800981 |
| 76 | Tetany (HP:0001281) | 2.37905027 |
| 77 | Renal tubular acidosis (HP:0001947) | 2.35255075 |
| 78 | Aortic dissection (HP:0002647) | 2.33813665 |
| 79 | Aortic regurgitation (HP:0001659) | 2.33089991 |
| 80 | Wrist flexion contracture (HP:0001239) | 2.31543655 |
| 81 | Fragile nails (HP:0001808) | 2.27792365 |
| 82 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.24316165 |
| 83 | Distal lower limb muscle weakness (HP:0009053) | 2.23709310 |
| 84 | Sudden death (HP:0001699) | 2.21796892 |
| 85 | Trismus (HP:0000211) | 2.20620003 |
| 86 | Knee flexion contracture (HP:0006380) | 2.20413105 |
| 87 | Turricephaly (HP:0000262) | 2.19697411 |
| 88 | Colitis (HP:0002583) | 2.19423563 |
| 89 | Soft skin (HP:0000977) | 2.18636876 |
| 90 | Abnormality of the vertebral endplates (HP:0005106) | 2.16141985 |
| 91 | Abnormality of the femoral head (HP:0003368) | 2.16071173 |
| 92 | Bulbar palsy (HP:0001283) | 2.13667348 |
| 93 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.12735245 |
| 94 | Abnormality of dentin (HP:0010299) | 2.12517245 |
| 95 | Neurofibrillary tangles (HP:0002185) | 2.11098458 |
| 96 | Down-sloping shoulders (HP:0200021) | 2.10529169 |
| 97 | Bowed forearm bones (HP:0003956) | 2.08574962 |
| 98 | Bowing of the arm (HP:0006488) | 2.08574962 |
| 99 | Limited hip movement (HP:0008800) | 2.08541075 |
| 100 | Elbow flexion contracture (HP:0002987) | 2.08273497 |
| 101 | Hypoplastic heart (HP:0001961) | 2.08219682 |
| 102 | Axonal loss (HP:0003447) | 2.06898461 |
| 103 | Achilles tendon contracture (HP:0001771) | 2.06881955 |
| 104 | Bladder diverticulum (HP:0000015) | 2.06759420 |
| 105 | Exercise-induced myalgia (HP:0003738) | 2.05224773 |
| 106 | Calf muscle hypertrophy (HP:0008981) | 2.03603293 |
| 107 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.03545545 |
| 108 | Exercise-induced muscle cramps (HP:0003710) | 2.01133588 |
| 109 | Upper limb amyotrophy (HP:0009129) | 1.99904216 |
| 110 | Distal upper limb amyotrophy (HP:0007149) | 1.99904216 |
| 111 | Chin dimple (HP:0010751) | 1.99897671 |
| 112 | Mitral valve prolapse (HP:0001634) | 1.99769691 |
| 113 | Coxa vara (HP:0002812) | 1.99185311 |
| 114 | Lower limb amyotrophy (HP:0007210) | 1.99109459 |
| 115 | Abnormal drinking behavior (HP:0030082) | 1.98719996 |
| 116 | Polydipsia (HP:0001959) | 1.98719996 |
| 117 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.98489133 |
| 118 | Ankle clonus (HP:0011448) | 1.98256173 |
| 119 | EMG: neuropathic changes (HP:0003445) | 1.96944874 |
| 120 | Waddling gait (HP:0002515) | 1.96795058 |
| 121 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.96682163 |
| 122 | Overgrowth (HP:0001548) | 1.96663298 |
| 123 | Short nail (HP:0001799) | 1.96412048 |
| 124 | Increased density of long bones (HP:0006392) | 1.95654797 |
| 125 | Hyperacusis (HP:0010780) | 1.95325791 |
| 126 | Peritonitis (HP:0002586) | 1.94559438 |
| 127 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.94514674 |
| 128 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.94388679 |
| 129 | Hypoplastic ischia (HP:0003175) | 1.93643404 |
| 130 | Flat capital femoral epiphysis (HP:0003370) | 1.93586253 |
| 131 | Bronchomalacia (HP:0002780) | 1.92688074 |
| 132 | Camptodactyly of toe (HP:0001836) | 1.90761865 |
| 133 | Flattened epiphyses (HP:0003071) | 1.90057563 |
| 134 | Tarsal synostosis (HP:0008368) | 1.89990954 |
| 135 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.89764539 |
| 136 | Abnormality of femoral epiphyses (HP:0006499) | 1.89764539 |
| 137 | Generalized muscle weakness (HP:0003324) | 1.87868425 |
| 138 | Easy fatigability (HP:0003388) | 1.87072899 |
| 139 | Limb-girdle muscle weakness (HP:0003325) | 1.86841357 |
| 140 | Prolonged neonatal jaundice (HP:0006579) | 1.86788267 |
| 141 | Neonatal short-limb short stature (HP:0008921) | 1.86648227 |
| 142 | Dilatation of the ascending aorta (HP:0005111) | 1.86520445 |
| 143 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.85390949 |
| 144 | Mesomelia (HP:0003027) | 1.84981998 |
| 145 | Retinal atrophy (HP:0001105) | 1.84022141 |
| 146 | Myotonia (HP:0002486) | 1.83619937 |
| 147 | Abnormality of the 2nd finger (HP:0004100) | 1.82798101 |
| 148 | Coronal craniosynostosis (HP:0004440) | 1.81771664 |
| 149 | Infantile muscular hypotonia (HP:0008947) | 1.81553158 |
| 150 | Abnormality of the thoracic spine (HP:0100711) | 1.81474006 |
| 151 | Hypophosphatemia (HP:0002148) | 1.81251220 |
| 152 | Neck muscle weakness (HP:0000467) | 1.80976496 |
| 153 | Protuberant abdomen (HP:0001538) | 1.80553366 |
| 154 | Genu recurvatum (HP:0002816) | 1.80498645 |
| 155 | Supranuclear gaze palsy (HP:0000605) | 1.80330926 |
| 156 | Increased serum ferritin (HP:0003281) | 1.80078856 |
| 157 | Hyperparathyroidism (HP:0000843) | 1.79717250 |
| 158 | Mitral regurgitation (HP:0001653) | 1.79183022 |
| 159 | Lymphangioma (HP:0100764) | 1.75980647 |
| 160 | Polygenic inheritance (HP:0010982) | 1.75595914 |
| 161 | Increased cerebral lipofuscin (HP:0011813) | 1.74896075 |
| 162 | Short femoral neck (HP:0100864) | 1.74202339 |
| 163 | Abnormality of the Achilles tendon (HP:0005109) | 1.73911958 |
| 164 | Bundle branch block (HP:0011710) | 1.73454064 |
| 165 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.72090641 |
| 166 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.72011855 |
| 167 | Abnormality of lateral ventricle (HP:0030047) | 1.71942490 |
| 168 | Lumbar hyperlordosis (HP:0002938) | 1.71771200 |
| 169 | Abdominal distention (HP:0003270) | 1.71318470 |
| 170 | Hypercalciuria (HP:0002150) | 1.70915301 |
| 171 | Bell-shaped thorax (HP:0001591) | 1.70759091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 6.81832959 |
| 2 | TRIB3 | 5.18903281 |
| 3 | TTN | 4.87768649 |
| 4 | PKN2 | 2.98189490 |
| 5 | DDR2 | 2.97716768 |
| 6 | MOS | 2.65401618 |
| 7 | IRAK3 | 2.63241147 |
| 8 | TLK1 | 2.46147634 |
| 9 | EPHB2 | 2.41273683 |
| 10 | PDGFRA | 2.41134657 |
| 11 | ERN1 | 2.26081569 |
| 12 | LATS1 | 2.14057184 |
| 13 | LRRK2 | 2.13373720 |
| 14 | LATS2 | 2.10751933 |
| 15 | MAP3K6 | 1.94801129 |
| 16 | ILK | 1.84584186 |
| 17 | MAP3K10 | 1.82380820 |
| 18 | PIK3CG | 1.78024760 |
| 19 | EPHA2 | 1.77238377 |
| 20 | PTK6 | 1.73237309 |
| 21 | PAK4 | 1.72463517 |
| 22 | PAK3 | 1.61306041 |
| 23 | MARK2 | 1.59203595 |
| 24 | MUSK | 1.53580449 |
| 25 | PAK2 | 1.50627068 |
| 26 | FER | 1.49072063 |
| 27 | TAOK1 | 1.43971701 |
| 28 | RIPK1 | 1.43927601 |
| 29 | BMX | 1.40730661 |
| 30 | PTK2 | 1.40314549 |
| 31 | ROCK2 | 1.38368615 |
| 32 | EEF2K | 1.36547470 |
| 33 | PIM2 | 1.36481443 |
| 34 | MAP3K11 | 1.32629320 |
| 35 | TRPM7 | 1.32186989 |
| 36 | TBK1 | 1.31949056 |
| 37 | MAP2K1 | 1.31263098 |
| 38 | OBSCN | 1.30568219 |
| 39 | TGFBR1 | 1.27530504 |
| 40 | MST1R | 1.24487600 |
| 41 | DYRK3 | 1.23948705 |
| 42 | MET | 1.20836191 |
| 43 | MAPKAPK3 | 1.15064838 |
| 44 | RPS6KA6 | 1.13787917 |
| 45 | ROCK1 | 1.13688440 |
| 46 | EPHB1 | 1.10306502 |
| 47 | LIMK1 | 1.09628461 |
| 48 | DAPK3 | 1.08855136 |
| 49 | MARK3 | 1.08580285 |
| 50 | MAP2K6 | 1.06916403 |
| 51 | SIK2 | 1.03973180 |
| 52 | DAPK2 | 0.98877129 |
| 53 | TNK2 | 0.94302703 |
| 54 | MAP3K3 | 0.91096942 |
| 55 | NTRK1 | 0.90247014 |
| 56 | RPS6KB2 | 0.89850548 |
| 57 | ERBB3 | 0.89082441 |
| 58 | CDK6 | 0.88366635 |
| 59 | MAP2K3 | 0.85232073 |
| 60 | MAP3K1 | 0.84946684 |
| 61 | TAOK2 | 0.84274534 |
| 62 | NEK9 | 0.82552315 |
| 63 | PIK3CA | 0.82119837 |
| 64 | PTK2B | 0.81528331 |
| 65 | FGFR1 | 0.81223998 |
| 66 | CDK15 | 0.81129420 |
| 67 | CDK14 | 0.80922817 |
| 68 | MAP4K1 | 0.79272797 |
| 69 | PHKG2 | 0.79198649 |
| 70 | PHKG1 | 0.79198649 |
| 71 | SMG1 | 0.78851126 |
| 72 | MAPK12 | 0.78231562 |
| 73 | MTOR | 0.77102563 |
| 74 | NTRK3 | 0.76518726 |
| 75 | CDK18 | 0.74357670 |
| 76 | CDK8 | 0.74054763 |
| 77 | CDK11A | 0.73854693 |
| 78 | PRPF4B | 0.73047207 |
| 79 | NME1 | 0.71656685 |
| 80 | STK16 | 0.70873631 |
| 81 | ARAF | 0.70868563 |
| 82 | PRKD1 | 0.70391867 |
| 83 | PAK6 | 0.69904348 |
| 84 | MAP3K9 | 0.67705495 |
| 85 | CSK | 0.66549462 |
| 86 | DYRK1B | 0.66510330 |
| 87 | ABL2 | 0.66482652 |
| 88 | STK3 | 0.66013602 |
| 89 | CHUK | 0.64654867 |
| 90 | PDGFRB | 0.63803860 |
| 91 | MATK | 0.63203106 |
| 92 | DMPK | 0.62964385 |
| 93 | LMTK2 | 0.62201302 |
| 94 | TYRO3 | 0.62189127 |
| 95 | PAK1 | 0.61588125 |
| 96 | MARK1 | 0.58817975 |
| 97 | MAPK4 | 0.58748726 |
| 98 | TGFBR2 | 0.57613721 |
| 99 | NTRK2 | 0.56598110 |
| 100 | STK38L | 0.56010998 |
| 101 | AKT2 | 0.55905771 |
| 102 | MAP2K2 | 0.55612293 |
| 103 | MAP3K13 | 0.55352718 |
| 104 | CDK12 | 0.55268886 |
| 105 | PRKCH | 0.53969806 |
| 106 | PDPK1 | 0.53343117 |
| 107 | NME2 | 0.52595984 |
| 108 | PRKD2 | 0.52458096 |
| 109 | STK10 | 0.51457149 |
| 110 | BRAF | 0.50340125 |
| 111 | SIK1 | 0.50319013 |
| 112 | PKN1 | 0.50080410 |
| 113 | MYLK | 0.49174355 |
| 114 | BCKDK | 0.48309133 |
| 115 | FGFR2 | 0.48261710 |
| 116 | DAPK1 | 0.48237900 |
| 117 | PRKCI | 0.45015878 |
| 118 | CAMK2G | 0.44254790 |
| 119 | ICK | 0.44218122 |
| 120 | RPS6KA1 | 0.43823486 |
| 121 | RET | 0.43179614 |
| 122 | CDC42BPA | 0.42886647 |
| 123 | ZAK | 0.42452769 |
| 124 | ADRBK1 | 0.42363924 |
| 125 | RPS6KA2 | 0.42143157 |
| 126 | MINK1 | 0.41352861 |
| 127 | MAP3K8 | 0.40534676 |
| 128 | BMPR1B | 0.40198687 |
| 129 | MAP2K7 | 0.39780481 |
| 130 | INSR | 0.38163235 |
| 131 | IKBKB | 0.38144425 |
| 132 | GSK3A | 0.37894599 |
| 133 | SIK3 | 0.37888222 |
| 134 | WNK1 | 0.37693582 |
| 135 | STK38 | 0.36589139 |
| 136 | WNK4 | 0.36426825 |
| 137 | TESK1 | 0.34126362 |
| 138 | CAMK2B | 0.33793918 |
| 139 | PRKAA1 | 0.32401523 |
| 140 | MAPK8 | 0.32362250 |
| 141 | CAMKK1 | 0.32116268 |
| 142 | IRAK4 | 0.31716462 |
| 143 | PRKD3 | 0.30448161 |
| 144 | MELK | 0.29810830 |
| 145 | HIPK2 | 0.29405647 |
| 146 | ALK | 0.28008241 |
| 147 | MAPK9 | 0.27988815 |
| 148 | RPS6KC1 | 0.27404129 |
| 149 | RPS6KL1 | 0.27404129 |
| 150 | MAP3K7 | 0.26787918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.34515250 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.42506735 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.28379208 |
| 4 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.25106141 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.19543644 |
| 6 | Focal adhesion_Homo sapiens_hsa04510 | 2.72634994 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.70976774 |
| 8 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 2.52212998 |
| 9 | Bladder cancer_Homo sapiens_hsa05219 | 2.46872316 |
| 10 | Basal cell carcinoma_Homo sapiens_hsa05217 | 2.31550519 |
| 11 | Hippo signaling pathway_Homo sapiens_hsa04390 | 2.29613352 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.98370414 |
| 13 | Tight junction_Homo sapiens_hsa04530 | 1.97853040 |
| 14 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.89691624 |
| 15 | Amoebiasis_Homo sapiens_hsa05146 | 1.84425876 |
| 16 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.78800598 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 1.78276930 |
| 18 | Adherens junction_Homo sapiens_hsa04520 | 1.75336982 |
| 19 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.62327016 |
| 20 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.60855895 |
| 21 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.60409220 |
| 22 | Melanogenesis_Homo sapiens_hsa04916 | 1.60103262 |
| 23 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.57261251 |
| 24 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.56687807 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.54960202 |
| 26 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.54254053 |
| 27 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.51068503 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.49853966 |
| 29 | Axon guidance_Homo sapiens_hsa04360 | 1.49353802 |
| 30 | Glioma_Homo sapiens_hsa05214 | 1.45689323 |
| 31 | Melanoma_Homo sapiens_hsa05218 | 1.44744869 |
| 32 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.40477427 |
| 33 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.39454598 |
| 34 | Galactose metabolism_Homo sapiens_hsa00052 | 1.35742358 |
| 35 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.35496358 |
| 36 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.34247514 |
| 37 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.34243118 |
| 38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.33648351 |
| 39 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.32621060 |
| 40 | Ribosome_Homo sapiens_hsa03010 | 1.29849782 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.28494987 |
| 42 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.25122220 |
| 43 | Gap junction_Homo sapiens_hsa04540 | 1.21154937 |
| 44 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.16852940 |
| 45 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.15764053 |
| 46 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.14258085 |
| 47 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.13053030 |
| 48 | Prion diseases_Homo sapiens_hsa05020 | 1.12767920 |
| 49 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.12354015 |
| 50 | Prostate cancer_Homo sapiens_hsa05215 | 1.10170081 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.08414012 |
| 52 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.07242319 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 1.07049035 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04923122 |
| 55 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.04517870 |
| 56 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.01784433 |
| 57 | Histidine metabolism_Homo sapiens_hsa00340 | 0.98419736 |
| 58 | Endometrial cancer_Homo sapiens_hsa05213 | 0.96187394 |
| 59 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.95560779 |
| 60 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.95206518 |
| 61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.95054446 |
| 62 | Pathways in cancer_Homo sapiens_hsa05200 | 0.94123492 |
| 63 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.93442820 |
| 64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.92254011 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90502342 |
| 66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.89852669 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89366696 |
| 68 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.89120085 |
| 69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88633514 |
| 70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.86973773 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86671687 |
| 72 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.85870202 |
| 73 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.84516174 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.81933998 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.79504590 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.79373765 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79217887 |
| 78 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.78915271 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77772697 |
| 80 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.75896059 |
| 81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74601109 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.74428526 |
| 83 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.73578405 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72263016 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71763871 |
| 86 | Insulin secretion_Homo sapiens_hsa04911 | 0.71634902 |
| 87 | Salivary secretion_Homo sapiens_hsa04970 | 0.71290565 |
| 88 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71266832 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70139546 |
| 90 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.69938918 |
| 91 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.69605772 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69130732 |
| 93 | Malaria_Homo sapiens_hsa05144 | 0.68578138 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67684732 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66599631 |
| 96 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63814438 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63282787 |
| 98 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.63125707 |
| 99 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.62340846 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61782015 |
| 101 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61314446 |
| 102 | Salmonella infection_Homo sapiens_hsa05132 | 0.60885419 |
| 103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60863823 |
| 104 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60854258 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60777720 |
| 106 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.60760161 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60756896 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60043591 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60008869 |
| 110 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59985341 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59492904 |
| 112 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59471803 |
| 113 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.58426666 |
| 114 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.57939922 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57798281 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55855787 |
| 117 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54729116 |
| 118 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.54713462 |
| 119 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.54393745 |
| 120 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.53119112 |
| 121 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.52503330 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.52008699 |
| 123 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.51863870 |
| 124 | Long-term depression_Homo sapiens_hsa04730 | 0.51761856 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51662120 |
| 126 | Apoptosis_Homo sapiens_hsa04210 | 0.51268560 |
| 127 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51208176 |
| 128 | Cocaine addiction_Homo sapiens_hsa05030 | 0.50586869 |
| 129 | Long-term potentiation_Homo sapiens_hsa04720 | 0.49154793 |
| 130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49056557 |
| 131 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.48849687 |
| 132 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.48528299 |
| 133 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47016410 |
| 134 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46602051 |
| 135 | Sulfur relay system_Homo sapiens_hsa04122 | 0.45914303 |
| 136 | Alzheimers disease_Homo sapiens_hsa05010 | 0.45730206 |
| 137 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.45648529 |
| 138 | Renin secretion_Homo sapiens_hsa04924 | 0.45023789 |
| 139 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.44937113 |
| 140 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43774229 |
| 141 | Shigellosis_Homo sapiens_hsa05131 | 0.42690812 |
| 142 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42476994 |
| 143 | Insulin resistance_Homo sapiens_hsa04931 | 0.41632955 |
| 144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38756423 |
| 145 | Parkinsons disease_Homo sapiens_hsa05012 | 0.38297439 |
| 146 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37629337 |

